BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 40577)

  • 1. Pipotiazine pharmacokinetics after p.o. and i.v. administration in man. Correlation between blood levels and effect on the handwriting area.
    De Schepper PJ; Vranckx C; Verbeeck R; Van den Berghe ML
    Arzneimittelforschung; 1979; 29(7):1056-62. PubMed ID: 40577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Initial results of a pharmacokinetic study of pipothiazine and its palmitic ester (Piportil L4) in a schizophrenic population].
    Girard M; Granier F; Schmitt L; Cotonat J; Escande M; Blanc M
    Encephale; 1984; 10(4):171-6. PubMed ID: 6149927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of amiodarone after intravenous and oral administration.
    Anastasiou-Nana M; Levis GM; Moulopoulos S
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):524-9. PubMed ID: 7174155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and disposition of clenbuterol in the horse.
    Soma LR; Uboh CE; Guan F; Moate P; Luo Y; Teleis D; Li R; Birks EK; Rudy JA; Tsang DS
    J Vet Pharmacol Ther; 2004 Apr; 27(2):71-7. PubMed ID: 15096103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pipotiazine palmitate: an evaluation of a new long acting intramuscular antipsychotic agent in severely ill schizophrenic patients.
    Gallant DM; Mielke D; Bishop G; Oelsner T; Guerrero-Figueroa R
    Dis Nerv Syst; 1975 Apr; 36(4):193-6. PubMed ID: 1090427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of florfenicol and its major metabolite, florfenicol amine, in rabbits.
    Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
    J Vet Pharmacol Ther; 2007 Feb; 30(1):32-6. PubMed ID: 17217398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicokinetics of lambda-cyhalothrin in rats.
    Anadón A; Martínez M; Martínez MA; Díaz MJ; Martínez-Larrañaga MR
    Toxicol Lett; 2006 Aug; 165(1):47-56. PubMed ID: 16513299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of vinpocetine in humans.
    Vereczkey L; Czira G; Tamás J; Szentirmay Z; Botár Z; Szporny L
    Arzneimittelforschung; 1979; 29(6):957-60. PubMed ID: 582791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of azapropazone following single oral and intravenous doses.
    Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
    Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute bioavailability of amezinium. A cross-over study after i.v. and p.o. application.
    Kaumeier S; Kehrhahn OH; Morgenthaler H; Neugebauer G
    Arzneimittelforschung; 1981; 31(9a):1653-7. PubMed ID: 7197980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and body distribution of amiodarone in man.
    Plomp TA; van Rossum JM; Robles de Medina EO; van Lier T; Maes RA
    Arzneimittelforschung; 1984; 34(4):513-20. PubMed ID: 6540111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of luxabendazole after oral and intravenous administration to sheep.
    Ortiz AI; Alvarez-Bujidos L; Ferre I; Ordóñez D
    Am J Vet Res; 1997 Nov; 58(11):1263-6. PubMed ID: 9361890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of a new beta-adrenoceptor blocking agent, LF 17-895, in man.
    Gugler R; Kreis L; Dengler HJ
    Arzneimittelforschung; 1975 Jul; 25(7):1067-72. PubMed ID: 241357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on pharmacokinetics and biotransformation of reproterol in animal and man (author's transl)].
    Niebch G; Obermeier K; Vergin H; Thiemer K
    Arzneimittelforschung; 1977; 27(12):37-45. PubMed ID: 576829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Crossover pharmacokinetic study of quinupramine in 6 subjects].
    Bouquet S; Lefebvre MA; Girault J; Fourtillan JB
    Encephale; 1982; 8(4):449-63. PubMed ID: 7151737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.